Literature DB >> 11831502

Cognitive deficits among methamphetamine users with attention deficit hyperactivity disorder symptomatology.

Tiffanie Sim1, Sara L Simon, Catherine P Domier, Kimberly Richardson, Richard A Rawson, Walter Ling.   

Abstract

Understanding the association between attention deficit hyperactivity disorder (ADHD) and substance abuse, specifically methamphetamine (MA) abuse, is challenging, partly because little is known about the specific constellation of cognitive impairments produced by MA. The present investigation serves to address this relationship by comparing the cognitive performance of MA abusers with ADHD symptomatology (n = 28) and MA abusers without ADHD symptomatology (n = 41) on tests of attention, memory and general intellectual functioning, executive functioning, problem solving, verbal fluency, and abstract thinking. Both MA samples had deficiencies in measures of memory and learning function, psychomotor speed and abstract thinking when compared to a control group (n = 40). Additional deficits were noted on tasks involving executive functioning, attention, and general intellectual functioning in MA abusers with ADHD symptomatology. The preliminary data suggests that executive function deficits and some of the symptoms associated with long-term MA use may be due to the fact that a large proportion of MA addicts had ADHD symptomatology as children.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11831502     DOI: 10.1300/j069v21n01_07

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  21 in total

1.  Working memory deficits affect risky decision-making in methamphetamine users with attention-deficit/hyperactivity disorder.

Authors:  Nichole A Duarte; Steven Paul Woods; Alexandra Rooney; J Hampton Atkinson; Igor Grant
Journal:  J Psychiatr Res       Date:  2012-02-02       Impact factor: 4.791

2.  The impact of clinical and demographic variables on cognitive performance in methamphetamine-dependent individuals in rural South Carolina.

Authors:  Kimber L Price; Stacia M DeSantis; Annie N Simpson; Bryan K Tolliver; Aimee L McRae-Clark; Michael E Saladin; Nathaniel L Baker; Mark T Wagner; Kathleen T Brady
Journal:  Am J Addict       Date:  2011-07-18

3.  Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findings.

Authors:  Mariana Cherner; Chad Bousman; Ian Everall; Daniel Barron; Scott Letendre; Florin Vaida; J Hampton Atkinson; Robert Heaton; Igor Grant
Journal:  J Int Neuropsychol Soc       Date:  2010-08-23       Impact factor: 2.892

Review 4.  The need for speed: an update on methamphetamine addiction.

Authors:  Alasdair M Barr; William J Panenka; G William MacEwan; Allen E Thornton; Donna J Lang; William G Honer; Tania Lecomte
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

Review 5.  Neurocognitive effects of methamphetamine: a critical review and meta-analysis.

Authors:  J Cobb Scott; Steven Paul Woods; Georg E Matt; Rachel A Meyer; Robert K Heaton; J Hampton Atkinson; Igor Grant
Journal:  Neuropsychol Rev       Date:  2007-09       Impact factor: 7.444

6.  Poor working memory and reduced blood pressure levels in concurrent users of khat and tobacco.

Authors:  Motohiro Nakajima; Richard Hoffman; Mustafa Al'Absi
Journal:  Nicotine Tob Res       Date:  2013-09-28       Impact factor: 4.244

7.  Overlapping cognitive patterns in schizophrenia and methamphetamine dependence.

Authors:  Ruth Salo; Susan Ravizza; Catherine Fassbender
Journal:  Cogn Behav Neurol       Date:  2011-12       Impact factor: 1.600

8.  Concurrent use of khat and tobacco is associated with verbal learning and delayed recall deficits.

Authors:  Richard Hoffman; Mustafa Al'absi
Journal:  Addiction       Date:  2013-07-12       Impact factor: 6.526

9.  Neuropscyhological Complications of HIV Disease and Substances of Abuse.

Authors:  Lisa R Norman; Anil Kumar
Journal:  Am J Infect Dis       Date:  2006

10.  Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat.

Authors:  Irina N Krasnova; Zuzana Justinova; Bruce Ladenheim; Subramaniam Jayanthi; Michael T McCoy; Chanel Barnes; John E Warner; Steven R Goldberg; Jean Lud Cadet
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.